Molecular Cancer Therapeutics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simmons, T. L.
Right arrow Articles by Gerwick, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simmons, T. L.
Right arrow Articles by Gerwick, W. H.
Related Collections
Right arrow Therapeutics and Targets
Right arrow Therapeutics and Targets: Experimental Therapeutics– Small Molecules
Mol Cancer Ther. 2005;4:333-342
© 2005 American Association for Cancer Research

Minireview

Marine natural products as anticancer drugs

T. Luke Simmons, Eric Andrianasolo, Kerry McPhail, Patricia Flatt and William H. Gerwick

College of Pharmacy, Oregon State University, Corvallis, Oregon

Requests for reprints: William H. Gerwick, Oregon State University, College of Pharmacy Building, 15th and Jefferson Avenue, Corvallis, OR 97331. Phone: 541-737-5801; Fax: 541-737-3999. E-mail: Bill.Gerwick{at}oregonstate.edu

The chemical and biological diversity of the marine environment is immeasurable and therefore is an extraordinary resource for the discovery of new anticancer drugs. Recent technological and methodologic advances in structure elucidation, organic synthesis, and biological assay have resulted in the isolation and clinical evaluation of various novel anticancer agents. These compounds range in structural class from simple linear peptides, such as dolastatin 10, to complex macrocyclic polyethers, such as halichondrin B; equally as diverse are the molecular modes of action by which these molecules impart their biological activity. This review highlights several marine natural products and their synthetic derivatives that are currently undergoing clinical evaluation as anticancer drugs.


1 The public literature available as of this writing indicates that NVP-LAQ824 is currently undergoing clinical evaluation; however, recent personal communications suggest that these trials have been discontinued.

2 http://www.pharmamar.com/en/pipeline/aplidin.cfm

3 http://www.ilexonc.com

4 Unpublished data.

Received 9/ 1/04; revised 11/24/04; accepted 12/ 3/04.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.